- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/12 - Cyclic peptides
Patent holdings for IPC class A61K 38/12
Total number of patents in this class: 2836
10-year publication summary
180
|
249
|
259
|
209
|
268
|
242
|
279
|
260
|
191
|
56
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
46 |
Aileron Therapeutics, Inc. | 85 |
40 |
Bristol-myers Squibb Company | 5080 |
32 |
Shanghai Techwell Biopharmaceutical Co., Ltd. | 66 |
28 |
Palatin Technologies, Inc. | 79 |
26 |
Polyphor AG | 101 |
26 |
Novartis AG | 11238 |
25 |
Apellis Pharmaceuticals, Inc. | 109 |
25 |
Xellia Pharmaceuticals ApS | 114 |
22 |
Ohio State Innovation Foundation | 1770 |
21 |
University of South Florida | 1817 |
20 |
Cidara Therapeutics, Inc. | 87 |
20 |
Ra Pharmaceuticals, Inc. | 76 |
20 |
Saint Regis Mohawk Tribe | 34 |
20 |
Bicyclerd Limited | 130 |
19 |
Ampio Pharmaceuticals, Inc. | 46 |
18 |
Helperby Therapeutics Limited | 61 |
18 |
Centre National de La Recherche Scientifique | 9632 |
17 |
President and Fellows of Harvard College | 5792 |
17 |
Rhythm Pharmaceuticals, Inc. | 63 |
17 |
Other owners | 2359 |